| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |